HANNAH JOHNSON: Open Payments
NPI 1881295269 · NOTTINGHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,400 in 310 payments from 22 companies in 2025. Trend: 2023 $5,929 · 2024 $7,115 · 2025 $6,400
Food & beverage: $6,120Education: $280
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $703 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 26 | $701 |
| Novartis Pharmaceuticals Corporation | 31 | $535 |
| LEO Pharma Inc. | 14 | $476 |
| Galderma Laboratories, L.P. | 25 | $465 |
| Organon LLC | 23 | $442 |
| Regeneron Healthcare Solutions, Inc. | 16 | $423 |
| Janssen Biotech, Inc. | 11 | $422 |
| PFIZER INC. | 27 | $417 |
| UCB, Inc. | 25 | $378 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, NEMLUVIO, ADBRY, Bimzelx, OPZELURA, ILUMYA.
Industry payments across MD — which companies pay providers there.
